ARIGHI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 5.697
AS - Asia 5.552
EU - Europa 4.834
SA - Sud America 564
AF - Africa 150
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.855
Nazione #
US - Stati Uniti d'America 5.437
CN - Cina 1.590
SG - Singapore 1.577
IT - Italia 1.214
GB - Regno Unito 1.068
DE - Germania 570
BD - Bangladesh 533
HK - Hong Kong 507
VN - Vietnam 453
BR - Brasile 433
SE - Svezia 417
RU - Federazione Russa 339
FR - Francia 270
IN - India 261
CA - Canada 172
NL - Olanda 171
IE - Irlanda 142
JP - Giappone 118
FI - Finlandia 115
TR - Turchia 114
ID - Indonesia 90
ES - Italia 87
KR - Corea 77
DK - Danimarca 68
CI - Costa d'Avorio 61
BE - Belgio 60
PL - Polonia 58
MX - Messico 48
AU - Australia 42
AR - Argentina 39
CH - Svizzera 37
AT - Austria 31
UA - Ucraina 29
MA - Marocco 28
GR - Grecia 27
IR - Iran 27
IQ - Iraq 26
RO - Romania 26
PH - Filippine 22
CO - Colombia 21
VE - Venezuela 20
CZ - Repubblica Ceca 19
PK - Pakistan 19
PT - Portogallo 17
UZ - Uzbekistan 16
ZA - Sudafrica 15
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
MY - Malesia 13
JO - Giordania 12
NO - Norvegia 12
PE - Perù 12
TW - Taiwan 12
EC - Ecuador 11
KZ - Kazakistan 10
IL - Israele 9
LT - Lituania 9
JM - Giamaica 8
NP - Nepal 8
NZ - Nuova Zelanda 8
UY - Uruguay 8
EG - Egitto 7
LU - Lussemburgo 7
QA - Qatar 7
AL - Albania 6
DZ - Algeria 6
RS - Serbia 6
KE - Kenya 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AZ - Azerbaigian 4
CR - Costa Rica 4
CU - Cuba 4
HR - Croazia 4
LB - Libano 4
NI - Nicaragua 4
PY - Paraguay 4
SA - Arabia Saudita 4
SI - Slovenia 4
BG - Bulgaria 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 16.822
Città #
Singapore 930
Southend 803
Ashburn 744
Hong Kong 439
Chandler 350
Milan 342
San Jose 339
Dallas 245
Beijing 213
Council Bluffs 209
Fairfield 207
Santa Clara 204
New York 195
Ann Arbor 160
Los Angeles 160
Dublin 133
Seattle 132
Hefei 130
Ho Chi Minh City 125
Frankfurt am Main 119
Berlin 116
Hanoi 116
Houston 115
Princeton 112
The Dalles 108
Wilmington 98
Cambridge 97
Guangzhou 95
Woodbridge 93
Buffalo 85
Moscow 85
Lauterbourg 84
Bengaluru 80
Toronto 79
Redwood City 74
Istanbul 73
Jakarta 71
Rome 70
Tokyo 65
Nanjing 62
Abidjan 61
Boardman 61
Shanghai 60
Phoenix 59
Helsinki 57
Munich 53
São Paulo 51
Turin 49
Columbus 44
Des Moines 44
Brussels 39
Dearborn 37
London 36
Jinan 35
Seoul 35
Kent 34
Nuremberg 33
Amsterdam 30
Naples 29
Shenyang 29
Warsaw 28
Cangzhou 27
Chicago 24
Da Nang 23
Duncan 23
Atlanta 22
Montreal 22
Changsha 21
Fuzhou 21
Turku 21
San Diego 19
Shenzhen 19
Chengdu 18
Norwalk 18
Vienna 18
Athens 17
Bologna 17
Central District 17
Hangzhou 17
Silver Spring 17
Tianjin 17
Brooklyn 16
Lappeenranta 16
Ottawa 16
Boston 15
Brescia 15
Wuhan 14
Madrid 13
Paris 13
Quanzhou 13
Zhengzhou 13
Adelaide 12
Baghdad 12
Bühl 12
Casablanca 12
Haiphong 12
Mexico City 12
Orem 12
Prague 12
San Francisco 12
Totale 9.511
Nome #
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 539
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 524
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 471
Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study 403
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study 382
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 356
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 339
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 336
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 299
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 283
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 271
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 266
Cerebrospinal fluid glutamate changes in functional movement disorders 265
Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia 257
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 255
The brain is hypothermic in patients with mitochondrial diseases 253
Diogenes syndrome in dementia: a case report 249
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 248
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 238
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 234
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 232
Circulating miRNAs as potential biomarkers in Alzheimer's disease 228
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 228
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 226
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 226
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease 225
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 225
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis 225
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study 221
Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study 220
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 217
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion : late-onset psychotic clinical presentation 214
Causal frontotemporal lobar degeneration mutations : a novel mutation in MAPT associated with non-fluent Progressive Aphasia phenotype 213
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 209
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 206
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation 205
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 198
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 198
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 198
PINK1 parkinsonism and Parkinson disease : distinguishable brain mitochondrial function and metabolomics 196
Inflammatory molecules in Frontotemporal Dementia : Cerebrospinal fluid signature of progranulin mutation carriers 194
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors 193
Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy 190
Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia 187
Teaching Neuroimage: Crowned Dens Syndrome, an Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 185
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 185
Differential miRNA expression in neural-enriched extracellular vesicles as potential biomarker for frontotemporal dementia and bipolar disorder 184
A “glympse” into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin‐4 for the assessment of glymphatic system in Alzheimer's disease and other dementias 182
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 177
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study 176
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 176
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy 175
Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study 173
Ischaemic Stroke of the Hand-Knob Area Due to Paradoxical Cerebral Air Embolism after Central Venous Catheterization—A Doubly Rare Occurrence: A Case Report and an Overview of Pathophysiology, Diagnosis, and Treatment 171
Central hyperthermia, brain hyperthermia and low hypothalamus temperature 165
Niemann-Pick Type C 1 (NPC1) and NPC2 gene variability in demented patients with evidence of brain amyloid deposition 165
Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 164
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 163
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 158
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis 156
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 152
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 151
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 148
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative 147
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis] 146
A critical review on structural neuroimaging studies in BD : a transdiagnostic perspective from psychosis to fronto-temporal dementia 143
Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study 143
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 139
Demenza frontotemporale: terapia sintomatica e prospettive future 137
Increased brain temperature in Parkinson's disease 134
Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes 129
Brain temperature in multiple sclerosis 122
Behavioral variant of frontotemporal dementia and homicide in a historical case 120
Serum neurofilament light is superior to glial fibrillary acidic protein to distinguish sporadic frontotemporal dementia from late-onset primary psychiatric disorders: a retrospective DIPPA-FTD study 117
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting 115
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 114
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 114
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia 112
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 87
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 84
Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration 73
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group 73
null 71
Accuracy of FDG-PET brain scan to differentiate sporadic bvFTD of mild severity from late onset psychiatric disorders 69
Semantic and phonemic advantages in Alzheimer's disease and behavioral variant-frontotemporal dementia: Insights from the Fluency Type Index 66
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI study 66
First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia 66
Glial and neuronal cell-free DNA in plasma of sporadic bvFTD and late onset primary psychiatric disease patients 49
Minds and machines: AI's transformative role in human identity and medicine 20
The role of neural derived extracellular vesicles micro-ribonucleic acid cargo in white matter integrity in early-onset and late-onset bipolar disorder 12
Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer’s Disease 10
null 3
Technology acceptance and perceived safety in AI-driven home monitoring for mild cognitive impairment 2
Medical Information Extraction With NLP-Powered QABots: A Real-World Scenario 1
Totale 17.432
Categoria #
all - tutte 50.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 0 0 182
2021/20221.204 101 111 64 64 102 99 67 70 144 90 66 226
2022/20231.388 170 192 110 145 118 226 45 85 146 25 88 38
2023/20241.221 47 65 88 96 303 80 108 81 46 75 107 125
2024/20252.952 91 255 95 285 223 173 181 289 131 319 317 593
2025/20267.173 625 430 612 576 511 428 1.058 240 701 493 935 564
Totale 17.432